Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Aligos Therapeutics, Inc.
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Aligos Therapeutics, Inc.
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Aligos Therapeutics, Inc.
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
$
ALGS
Aligos Therapeutics, Inc.
CIK:
0001799448
|
SEC Filings
INDENTURES
EX-4.3
algs-ex4_3.htm
Mar 5, 2026
EX-4.3
algs-ex4_3.htm
Mar 10, 2025
EX-4.1
d901857dex41.htm
Feb 12, 2025
EX-4.2
d901857dex42.htm
Feb 12, 2025
EX-4.6
d858933dex46.htm
Nov 6, 2024
EX-4.2
algs-ex4_2.htm
Nov 6, 2024
EX-4.2
algs-ex4_2.pdf
Nov 6, 2024
EX-4.1
d533607dex41.htm
Oct 25, 2023
EX-4.2
d533607dex42.htm
Oct 25, 2023
EX-4.4
d250018dex44.htm
Nov 4, 2021
EX-4.3
algs-ex43_785.htm
Mar 23, 2021
EX-4.2
d31402dex42.htm
Oct 9, 2020